Inspection about authenticity and integrity for clinical trial data of medical device

doi:10.12092/j.issn.1009-2501.2019.10.001

Abstract

Abstract:

In order to strengthen the supervision about clinical trials of medical devices, National Medical Products Administration (NMPA) inspects the clinical trials of medical devices to projects in the process of evaluation annually, and ensures the truth and validity about the data of clinical trials of medical devices. This paper summarizes the situation of supervision about clinical trials of medical devices in the past three years and the main problems existed in clinical trials of medical devices in China. The purpose is to strengthen the attention of applicants and clinical trial units to the quality of clinical trials, and to improve the level about clinical trials of medical devices in China.

Key words: medical device, clinical trial data, authenticity and integrity, inspection

CLC Number:

R969

ZHANG Zhengfu, WANG Jianan. Inspection about authenticity and integrity for clinical trial data of medical device[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(10): 1081-1084.

References

［1］国家药品监督管理局.《总局关于4个医疗器械注册申请项目临床试验监督抽查有关情况的公告（2016年第147号）》［EB/OL］. ［2016-09-07］.http://www.nmpa.gov.cn/WS04/CL2138/300207.html.
［2］国家药品监督管理局.《总局关于1个医疗器械注册申请项目临床试验监督抽查有关情况的公告（2016年第170号）》［EB/OL］. ［2016-10-26］.http://www.nmpa.gov.cn/WS04/CL2138/300224.html.
［3］国家药品监督管理局.《总局关于3个医疗器械注册申请项目临床试验监督抽查有关情况的公告（2016年第191号）》［EB/OL］.［2016-12-16］.http://www.nmpa.gov.cn/WS04/CL2138/300254.html.
［4］国家药品监督管理局.《总局关于3个医疗器械注册申请项目临床试验监督抽查有关情况的公告（2017年第107号）》［EB/OL］.［2017-09-05］.http://www.nmpa.gov.cn/WS04/CL2138/300390.html.
［5］国家药品监督管理局.《总局关于2017年第二批医疗器械临床试验监督抽查情况的公告（2017年第163号）》［EB/OL］.［2017-12-27］.http://www.nmpa.gov.cn/WS04/CL2138/300465.html.
［6］国家药品监督管理局.《国家药品监督管理局关于2018年第一批医疗器械临床试验监督抽查情况的公告（2018年第67号）》［EB/OL］.［2018-09-12］.http://www.nmpa.gov.cn/WS04/CL2138/330201.html.
［7］国家药品监督管理局.《关于2018年第二批医疗器械临床试验监督抽查情况的公告（2019年第38号）》［EB/OL］.［2019-05-06］.http://www.nmpa.gov.cn/WS04/CL2119/337624.html.
［8］国家药品监督管理局.《总局关于公布51家企业撤回101个医疗器械注册申请项目的公告（2016年第146号）》［EB/OL］.［2016-09-07］.http://www.nmpa.gov.cn/WS04/CL2138/300206.html.
［9］国家药品监督管理局.《总局关于公布44家企业撤回130个医疗器械注册申请项目的公告（2016年第169号）》［EB/OL］.［2016-10-26］.http://www.nmpa.gov.cn/WS04/CL2138/300223.html.
［10］国家药品监督管理局.《总局关于公布27家企业撤回32个医疗器械注册申请项目的公告（2016年第193号）》［EB/OL］.［2016-12-16］.http://www.nmpa.gov.cn/WS04/CL2138/300255.html.
［11］国家药品监督管理局.《总局关于公布169家企业撤回261个医疗器械注册申请项目的公告（2017年第174号）》［EB/OL］.［2018-01-02］.http://www.nmpa.gov.cn/WS04/CL2138/300477.html.

[1]	DAI Jiahui, SUN Sijia, XIE Xuefeng. Quality management and indicator system for clinical trials of medical devices [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 51-58.
[2]	LIU Xing, WU Ying, LI Yang, WANG Xiaomin. Analysis of ethical issue in the application of artificial intelligence medical devices [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 695-699.
[3]	JIANG Haihong, LI Xiao, LIU Yang. Four dimensions of receiving overseas clinical trial data about drug and medical devices [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 835-840.
[4]	LI Xiao, LIU Yang, WANG Xinyi. Problems and countermeasures in the supervision of clinical trials of medical devices [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(8): 841-845.
[5]	ZHU Huan, LIU Yuxiu, YU Hao. Automated inspection for SDTM define.xml based on metadata via SAS macro [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(11): 1248-1258.
[6]	WANG Xiu-qin, XIONG Ning-ning, LIU Shen-lin, LI Qi-yi, JIANG Meng, LIU Fang, GAOWei-min. Ethic review in clinical research:medical devices [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(12): 1437-1440.